Page last updated: 2024-11-10

1,2-diamino-4,5-methylenedioxybenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2-diamino-4,5-methylenedioxybenzene: used to determine alpha-keto acids in human serum & urine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3080788
SCHEMBL ID546296
MeSH IDM0164034

Synonyms (26)

Synonym
1,2-diamino-4,5-methylenedioxy-benzene
1,2-diamino-4,5-methylenedioxybenzene
1,2-dmb
38608-07-0
dmb cpd
1,2-diamino-4,5-methylene-dioxybenzene
1,3-benzodioxole-5,6-diamine
2h-1,3-benzodioxole-5,6-diamine
FT-0681958
818-15-5
AKOS009157224
SCHEMBL546296
SNHKEQOYVVRBQO-UHFFFAOYSA-N
1,3-benzodioxol-5,6-diamine
benzo[1,3]dioxole-5,6-diamine
FE-0725
benzo[d][1,3]dioxole-5,6-diamine
J-519723
DTXSID60191928
mfcd07780137
CS-0088593
D74701
10-heptadecynoic acid,6,12-dihydroxy-, methyl ester
EN300-247555
1,3-dioxaindane-5,6-diamine
PD150928
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.23)18.7374
1990's5 (16.13)18.2507
2000's9 (29.03)29.6817
2010's13 (41.94)24.3611
2020's3 (9.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.42 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index5.30 (4.65)
Search Engine Demand Index22.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]